Cargando…
Does Nirmatrelvir/Ritonavir Influence the Immune Response against SARS-CoV-2, Independently from Rebound?
Recurrence of coronavirus disease 19 (COVID-19) symptoms and SARS-CoV-2 viral load relapse have been reported in people treated with nirmatrelvir/ritonavir (NM/r). However, little is understood about the etiology of this phenomenon. Our aim was to investigate the relation between the host’s immune r...
Autores principales: | Panza, Francesca, Fiorino, Fabio, Pastore, Gabiria, Fiaschi, Lia, Tumbarello, Mario, Medaglini, Donata, Ciabattini, Annalisa, Montagnani, Francesca, Fabbiani, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609571/ https://www.ncbi.nlm.nih.gov/pubmed/37894265 http://dx.doi.org/10.3390/microorganisms11102607 |
Ejemplares similares
-
Trajectory of Spike-Specific B Cells Elicited by Two Doses of BNT162b2 mRNA Vaccine
por: Ciabattini, Annalisa, et al.
Publicado: (2023) -
Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?
por: Pettini, Elena, et al.
Publicado: (2021) -
B cell response after SARS-CoV-2 mRNA vaccination in people living with HIV
por: Polvere, Jacopo, et al.
Publicado: (2023) -
Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine
por: Ciabattini, Annalisa, et al.
Publicado: (2021) -
A third dose of mRNA-1273 vaccine improves SARS-CoV-2 immunity in HCT recipients with low antibody response after 2 doses
por: Pettini, Elena, et al.
Publicado: (2022)